Tarach J S, Nowicka-Tarach B M
2nd Department and Clinic of Internal Medicine, Medical University, ul. Jaczewskiego 8, 20-090 Lublin, Poland.
Med Sci Monit. 2000 Mar-Apr;6(2):421-5.
Primary myeloproliferative disorders (MPD) are often associated with hemostasis abnormalities, which may cause many thrombotic or hemorrhagic complications during the course of the disease. Clinical consequences following abnormal hemostatic conditions include various neurological manifestations. It is extremely difficult to predict and evaluate the risk and chance, that MPD patients will develop neurological symptoms. The up-to-date background of pathological thrombocytosis, as well as the neurological aspects of abnormal hemostasis during the course of myeloproliferative disorders have been reviewed in this study.
原发性骨髓增殖性疾病（MPD）常与止血异常相关，这可能在疾病过程中导致许多血栓形成或出血性并发症。止血异常状况后的临床后果包括各种神经学表现。预测和评估MPD患者出现神经症状的风险和可能性极其困难。本研究综述了病理性血小板增多症的最新背景以及骨髓增殖性疾病过程中止血异常的神经学方面。
